Temozolomide resistant MGMT negative/MMR proficient cancer cells rely on ATR signaling and homologous recombination for DNA repair and survival

被引：0
|
作者：
El Touny, Lara [1 ]
Harris, Erik [1 ]
Hose, Curtis [1 ]
Connelly, John [1 ]
Vengsarkar, Diana [1 ]
Monks, Anne [1 ]
Parchment, Ralph E. [1 ]
Doroshow, James H. [2 ]
Teicher, Beverly A. [2 ]
Rapisarda, Annamaria [1 ]
机构：
[1] FNLCR Leidos Biomed Res Inc, Frederick, MD USA
[2] NCI, NIH, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
270
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Temozolomide-resistant MGMT/MSI double-negative cancer cells rely on ATR signaling and homologous recombination for DNA repair and survival
    El Touny, Lara H.
    Harris, Erik
    Hose, Curtis
    Connelly, John
    Monks, Anne
    Newton, Dianne
    Stockwin, Luke
    Hollingshead, Melinda
    Parchment, Ralph
    Doroshow, James H.
    Teicher, Beverly A.
    Rapisarda, Annamaria
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [2] Survivin contributes to DNA repair by homologous recombination in breast cancer cells
    Vequaud, Eloise
    Desplanques, Gregoire
    Jezequel, Pascal
    Juin, Philippe
    Barille-Nion, Sophie
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (01) : 53 - 63
  • [3] Survivin contributes to DNA repair by homologous recombination in breast cancer cells
    Eloïse Véquaud
    Grégoire Desplanques
    Pascal Jézéquel
    Philippe Juin
    Sophie Barillé-Nion
    Breast Cancer Research and Treatment, 2016, 155 : 53 - 63
  • [4] Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival
    Li, DH
    Liu, H
    Jiao, L
    Chang, DZ
    Beinart, G
    Wolff, RA
    Evans, DB
    Hassan, MM
    Abbruzzese, JL
    CANCER RESEARCH, 2006, 66 (06) : 3323 - 3330
  • [5] (Z)-butylidenephthalide Restores Temozolomide Sensitivity to Temozolomide-resistant Malignant Glioma Cells by Downregulating Expression of the DNA Repair Enzyme MGMT
    Yen, S. Y.
    Harn, H. J.
    Lin, S. Z.
    Chen, S. R.
    Lin, P. C.
    Syu, F. J.
    Hsieh, D. K.
    Huang, M. H.
    Chiou, T. W.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S220 - S221
  • [6] Targeting homologous recombination-proficient triple negative cancer cells with a novel RAD51 inhibitor
    Neumann, Carola Anke
    Skoko, John J.
    Freeman, Bruce A.
    Schopfer, Francisco
    Woodcock, Steven Robert
    Chang, Fei
    Hong, Lisa
    Braden, Dennis Carl
    Uvalle, Crystal
    CANCER RESEARCH, 2022, 82 (04)
  • [7] Chromosomal aberrations and homologous recombination DNA repair activity in response to olaparib combined with inhibitors of ATR/CHK1 pathway in ovarian cancer cells sensitive and resistant to PARPi
    Biegala, L.
    Gajek, A.
    Marczak, A.
    Rogalska, A.
    FEBS OPEN BIO, 2022, 12 : 97 - 97
  • [8] DNA Repair by Homologous Recombination, But Not by Nonhomologous End Joining, Is Elevated in Breast Cancer Cells
    Mao, Zhiyong
    Jiang, Ying
    Liu, Xiang
    Seluanov, Andrei
    Gorbunova, Vera
    NEOPLASIA, 2009, 11 (07): : 683 - U83
  • [9] Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells
    Choi, Young Eun
    Battelli, Chiara
    Watson, Jacqueline
    Liu, Joyce
    Curtis, Jennifer
    Morse, Alexander N.
    Matulonis, Ursula A.
    Chowdhury, Dipanjan
    Konstantinopoulos, Panagiotis A.
    ONCOTARGET, 2014, 5 (09) : 2678 - 2687
  • [10] Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
    Neha Chopra
    Holly Tovey
    Alex Pearson
    Ros Cutts
    Christy Toms
    Paula Proszek
    Michael Hubank
    Mitch Dowsett
    Andrew Dodson
    Frances Daley
    Divya Kriplani
    Heidi Gevensleben
    Helen Ruth Davies
    Andrea Degasperi
    Rebecca Roylance
    Stephen Chan
    Andrew Tutt
    Anthony Skene
    Abigail Evans
    Judith M. Bliss
    Serena Nik-Zainal
    Nicholas C. Turner
    Nature Communications, 11
12345